[1]
El Hassouni, B.; Sarkisjan, D.; Vos, J.C.; Giovannetti, E.; Peters, G.J. Targeting the ribosome biogenesis key molecule fibrillarin to avoid chemoresistance. Curr. Med. Chem., 2019, 26(33), 6020-6032.
[2]
Zanforlin, E.; Zagotto, G.; Ribaudo, G.A. Chemical approach to overcome tyrosine kinase inhibitors resistance : learning from chronic myeloid leukemia. Curr. Med. Chem., 2019, 26(33), 6033-6052.
[3]
Ferroni, C.; Varchi, G. Non-steroidal androgen receptor antagonists and prostate cancer: a survey on chemical structures binding this fast-mutating target. Curr. Med. Chem., 2019, 26(33), 6053-6073.
[4]
Stankovic, T.; Dinic, J.; Podolski-Renic, A.; Musso, L.; Buric, S.S.; Dallavalle, S.; Pesic, M. Dual inhibitors as a new challenge for cancer multidrug resistance treatment. Curr. Med. Chem., 2019, 26(33), 6074-6106.